Received Feb 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
could not walk; felt achey all over my body; chills; fever; shins hurt soo bad; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of unable to walk in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced unable to walk (Verbatim: could not walk), general body pain (Verbatim: felt achey all over my body), chills (Verbatim: chills), fever (Verbatim: fever) and pain of lower extremities (Verbatim: shins hurt soo bad). The outcome of the unable to walk, general body pain, chills, fever and pain of lower extremities were not reported. It was unknown if the reporter considered the unable to walk, general body pain, chills, fever and pain of lower extremities to be related to Shingrix. It was unknown if the company considered the unable to walk, general body pain, chills, fever and pain of lower extremities to be related to Shingrix. Additional Information: GSK Receipt Date: 16-FEB-2026 This case was reported by a patient via interactive digital media. The patient reported that second portion of Shingrix was horrible. Patient shins hurt so bad could not walk, felt achey all over body, chills and fever. The batch number was not provided and unable to contact the reporter.